Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Drug maker Eli Lilly & Company agreed Thursday to pay federal and state governments more than $1.4 billion for its improper off-label marketing of Zyprexa, a popular schizophrenia medicine. Lilly will pay $800 million to settle civil charges, while $515 million will be paid as part of a guilty plea to a misdemeanor violation of the Food, Drug and Cosmetic Act. The Department of Justice called it the largest corporate criminal fine in history.

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2017 ALM Media Properties, LLC. All Rights Reserved.